• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,716.35(%)
  • Trent
    2,815.00 3,497.35(%)
  • Raymond
    1,024.00 1,024.00(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 530.65(%)
  • One 97
    1,829.50 1,829.50(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,727.35(%)
  • Britannia Inds.
    4,946.05 4,946.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jagsonpal Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 2171.0
  • ISIN : INE048B01035
232.89 0 (-0.04%)
  • As on 14 Sep 2026 (EOD)

  • Today’s Low

    228.01

  • Today’s High

    234.60

  • Open

    229.21

  • Perv Close

    232.99

  • 52W Low

    155.00

  • 52W High

    264.50

Key Indicators

  • P/E(TTM)

    32.73

  • Mar.Cap (₹Cr.)

    1,536.08

  • Div & Yield %

    1.74

  • Book Value(₹)

    41.84

  • Debt-Equity Ratio

    -0.04

  • AGM Date

    11-Sep-2026

  • EPS

    7.13

  • P/E Ratio

    32.73

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    1,536.08

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.19

  • BV (₹)

    41.60

  • Sales( ₹ in Cr.)

    287.23

  • NP (in Cr.)

    44.64

  • NP Var(%)

    41.0

  • Div%

    200.0

  • CPS (₹)

    8.20

  • EPS (₹)

    6.80

  • Traded Value (₹ in Lakhs)

    1,539.45

  • 52 Week High

    264.50

  • 52 Week Low

    155.00

  • Price BSE

    233.0

  • Price NSE

    233.00

  • Market Capital( in Cr.)

    1,539.45

  • P/C Ratio

    28.40

  • P/E Ratio

    34.40

  • Price Vs.BV

    6.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 287.23 268.72 208.70 236.71 217.58 187.95
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 287.23 268.72 208.70 236.71 217.58 187.95
Other Income 12.00 31.55 9.28 5.73 3.43 4.39
Stock Adjustments 0.93 2.13 -3.90 -4.30 -5.61 -5.28
Total Income 300.16 302.40 214.08 238.14 215.40 187.06
EXPENDITURE :            
Raw Materials 105.30 98.56 76.08 88.04 83.35 75.50
Power and Fuel Cost 0.18 0.19 0.17 0.29 0.47 0.52
Employee Cost 70.74 70.93 62.09 65.18 57.68 53.98
Other Manufacturing Expenses 1.49 1.16 0.73 0.52 0.91 0.48
Selling and Administration Expenses 51.32 48.14 40.80 41.66 42.50 31.88
Miscellaneous Expenses 3.13 4.46 1.87 6.03 2.05 1.22
Employee Benefit Expenses 70.74 70.93 62.09 65.18 57.68 53.98
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 232.16 223.44 181.74 201.72 186.95 163.59
Operating Profit 67.99 78.95 32.34 36.42 28.46 23.47
Interest 1.03 0.96 0.81 0.41 0.29 0.51
Gross Profit 66.96 77.99 31.53 36.01 28.17 22.96
Depreciation 9.44 8.13 1.66 1.21 1.53 1.09
Profit Before Tax 57.52 69.86 29.87 34.80 26.64 21.87
Current Tax 13.19 13.57 7.56 7.63 7.40 6.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.25 0.93 -0.15 0.46 0.38 -1.23
Reported Net Profit 43.08 55.36 22.46 26.72 18.86 17.06
Extraordinary Items -1.56 23.77 0.00 -1.89 0.50 0.00
Adjusted Net Profit 44.64 31.59 22.46 28.61 18.36 17.06
Adjustment below Net Profit 0.36 2.52 0.29 -1.56 3.95 -3.54
P & L Balance brought forward 148.85 104.19 94.54 69.37 58.59 47.69
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 16.66 13.23 13.10 0.00 12.02 2.62
P & L Balance carried down 175.64 148.85 104.19 94.54 69.37 58.59
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 200.00 125.00 100.00 100.00 80.00 20.00
Dividend Per Share(Rs) 4.00 2.50 5.00 5.00 4.00 1.00
Earnings Per Share-Unit Curr 6.43 8.34 8.50 10.20 7.20 6.51
Earnings Per Share(Adj)-Unit Curr 6.43 8.34 3.40 4.08 2.88 2.60
Book Value 41.01 36.08 70.88 60.65 50.68 43.55
Book Value(Adj)-Unit Curr 41.01 36.08 28.35 24.26 20.27 17.42

Shareholding Pattern

  • Promoter Group

    69.05%

  • Public Share Holding

    30.95%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 22,920,800 34.82 22,920,800 2
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 5,717,950 5,717,950.00 5,717,950 5,717,950
Sub Total 28,638,750 43.50 28,638,750 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,483,825 5.29 3,483,825 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 13,335,635 20.26 13,335,635 1
Others 0 0.00 0 0
Sub Total 16,819,460 25.55 16,819,460 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,000 0.00 1,500 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,513,624 2.30 1,513,624 6
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 771 0.00 771 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 405,741 0.62 405,741 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,922,136 2.92 1,921,636 16
2] Non Institution
Bodies Corporate 1,717,814 2.61 1,715,614 118
Clearing Members 17,030 0.03 17,030 21
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 427,569 0.65 427,569 386
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 559,851 0.85 559,851 488
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,226,803 3.38 2,226,803 4
Individuals holding nominal share capital up to Rs. 1 lakh 10,501,185 15.95 10,063,472 23,139
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 3,004,872 4.56 3,004,872 2
Sub Total 18,455,124 28.03 18,015,211 24,158
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 65,835,470 100.00 65,395,057 24,181

Company Background

Jagsonpal Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Jagsonpal Pharmaceuticals Ltd
  • BSE Code : 2171.0
  • ISIN : INE048B01035

  • Incorporation Year

    1978

  • Registered Office

    T-210 J
    Shahpur Jat, New Delhi,
    New Delhi-110049

  • Telephone

    91-011-46181100/46109900

  • FAX

    91-011-26498341

  • Chairman

    Harsha Raghavan

  • Managing Director

  • Company Secretary

    Pratham Rawal

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MCS Ltd
    F-65 1st Floor,
    Okhla Industrial Are,Phase-I
    Mumbai - New Delhi-110020

Jagsonpal Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jagsonpal Pharma 233.40 299.22 287.23 33.88 21.83
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77